J&J Fined $1.2B In Ark.'s Risperdal Marketing Suit
By Bibeka Shrestha ( April 11, 2012, 1:39 PM EDT) -- An Arkansas judge fined Johnson & Johnson and a subsidiary more than $1.2 billion on Wednesday after a jury sided with Arkansas in a suit claiming the companies committed Medicaid fraud through illegal marketing of antipsychotic drug Risperdal....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.